RetractedArticleOncoTargets and therapy2018

EZH2 contributes to 5-FU resistance in gastric cancer by epigenetically suppressing FBXO32 expression.

Chenyu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.